BioBehavioral Diagnostics Raising Series B Round
BioBehavioral Diagnostics Co., a Westford, Mass.-based developer of a diagnostic system for measuring the core components of Attention Deficit Hyperactivity Disorder (ADHD), has held a first close on a $10 million Series B round. Return backers include Sevin Rosen Funds and Tullis-Dickerson. The company previously raised $8.5 million.
1 February 2010•2 mins read
